AlloSource Announces Kerr Holbrook As Chief Commercial Officer

News provided by

May 14, 2015, 01:12 ET

CENTENNIAL, Colo., May 14, 2015 /PRNewswire-USNewswire/ -- AlloSource®, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Kerr Holbrook as Chief Commercial Officer.

Holbrook has more than 25 years of experience in a variety of sales, marketing and business development positions for healthcare service and manufacturing companies. He also has extensive experience bringing products to market, including collaborating with research and development, creating commercialization plans and managing their implementation. He received his MBA from the Kellogg Graduate School of Management at Northwestern University and his Bachelor's degree in Business Administration from the University of Kansas. Most recently, he served as Group Vice President of Strategy, Portfolio Management and Business Development for Covidien in Boulder, Colorado.

"Kerr's accomplished background and collaborative approach will enhance AlloSource's growth and our vision for the future," said Thomas Cycyota, AlloSource president and CEO. "His experience with strategic business development will help us ensure donated tissue reaches patients in need."

As Chief Commercial Officer, Holbrook will oversee AlloSource's commercialization strategy and organization, including distribution channels and customer service, both domestic and international. He will work closely with all departments in the organization to drive strategic partnerships and prioritize growth opportunities.

"Joining the leadership team at AlloSource is a great privilege," said Holbrook. "Being a part of this growing, innovative company provides an opportunity to contribute to an industry that is continually in need of biologic solutions for doctors and their patients."

About AlloSource
AlloSource is one of the largest nonprofit cellular and tissue networks in the country, offering more than 200 types of precise cellular, cartilage, bone, skin and soft-tissue allografts to advance patient healing. For more than 20 years, AlloSource's products have bridged the proven science of allografts with the advanced technology of cells, offering life-saving and life-enhancing possibilities in spine, sports medicine, foot and ankle, orthopedic, reconstructive, trauma and wound care procedures. As the world's largest processor of cellular bone allografts, fresh cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource delivers unparalleled expertise and service to its growing network of surgeons, partners, and the country's most reputable organ procurement organizations. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org or our educational website, allograftpossibilities.org.

Media Contact
Megan Duggan
AlloSource
720. 382. 2766
[email protected]

SOURCE AlloSource